Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 914-925

  Wang, Gang ^a,b   Ujiie, Hideyuki ^a   Shibaki, Akihiko ^a   Nishie, Wataru ^a   Tateishi, Yasuki ^a   Kikuchi, Kazuhiro ^a   Li, Qiang ^a   McMillan, James R ^a,b   Morioka, Hiroshi ^b   Sawamura, Daisuke ^a   Nakamura, Hideki ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COLLAGEN; COLLAGEN 17; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT 19; IMMUNOGLOBULIN F(AB) FRAGMENT B4; RECOMBINANT ANTIBODY; RECOMBINANT FAB ANTIBODY FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; BLISTER; BULLOUS PEMPHIGOID; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PHAGE DISPLAY; PRIORITY JOURNAL; TISSUE INJURY;

EID: 76149144802     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090744     Document Type: Article

References (34)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243
2. Holers VM: The complement system as a therapeutic target in autoimmunity. Clin Immunol 2003,107:140-151
3. Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H: Humanization of autoantigen. Nat Med 2007, 13:378-383
4. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, Diaz LA: The role of complement in experimental bullous pemphigoid. J Clin Invest 1995, 95:1539-1544
5. Mewar D, Wilson AG: Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother 2006, 60:648-655
6. D'Cruz DP, Khamashta MA, Hughes GRV: Systemic lupus erythematosus. Lancet 2007, 369:587-596
7. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003, 112:1644-1654
8. Zhao M, Trimbeger ME, Li N, Diaz LA, Shapiro SD, Liu Z: Role of FcRs in animal model of autoimmune bullous pemphigoid. J Immunol 2006, 177:3398-3405
9. Nelson KC, Zhao M, Schroeder PR, Li N, Wetse RA, Diaz LA, Liu Z: Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest 2006, 116:2892-2900
10. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen BP180. J Clin Invest 1993, 92:2480-2488
11. Liu Z: Bullous Pemphigoid: Using animal models to study the immunopathology. J Investig Dermatol Symp Proc 2004, 9:41-46
12. Yancey KB: The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005, 115:825-828
13. Girardi G, Redecha P, Salmon JE: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004, 10:1222-1226
14. Atkinson JP: Complement system on the attack in autoimmunity. J Clin Invest 2003, 112:1639-1641
15. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA: Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993, 151:5742-5750
16. Wang Z, Wang Y, Li Z, Li J, Dong Z: Humanization of a mouse monoclonal antibody neutralizing TNF-α by guided selection. J Immunol Methods 2000, 241:171-184
17. Barbas III CF, Kang AS, Lerner RA, Benkovic SJ: Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 1991, 88:7978-7982
18. Little M, Breitling F, Dubel S, Fuchs P, Braunagel M: Human antibody libraries in Escherichia coli. J Biotechnol 1995, 41:187-195
19. Clackson T, Hoogenboom HR, Griffiths AD, Winter G: Making antibody fragments using phage display libraries. Nature 1991, 352: 624-628
20. Wang G, Liu YF, Li CY, Lu N, Gao TW, Hua B, Wang Y: Cloning and characterization of antikeratin human antibodies using a semisynthetic phage antibody library. Arch Dermatol Res 2004, 296:270-277
21. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G: Bypassing immunization of human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991, 222:581-597
22. Hoogenboom HR: Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005, 23:1105-1116
23. Fairley JA, Fu CL, Giudice GJ: Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J Invest Dermatol 2005, 125:467-472
24. Shimizu H, Masunaga T, Ishiko A, Hashimoto T, Garrod DR, Shida H, Nishikawa T: Demonstration of desmosomal antigens by electron microscopy using cryofixed and cryosubstituted skin with silver-enhanced gold probe. J Histochem Cytochem 1994, 42:687-692
25. McMillan JR, Akiyama M, Nakamura H, Shimizu H: Colocalization of multiple laminin isoforms predominantly beneath hemidesmosomes in the upper lamina densa of the epidermal basement membrane. J Histochem Cytochem 2006, 54:109-111
26. Nonaka S, Ishiko A, Masunaga T, Akiyama M, Owaribe K, Shimizu H, Nishikawa T: The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo. J Invest Dermatol 2000, 115:889-892
27. Khumalo N, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D: Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2005 (3):CD002292
28. Schumann H, Baetge J, Tasanen K, Wojnarowska F, Schäcke H, Zillikens D, Bruckner-Tuderman L: The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000, 156:685-695
29. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T: Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993, 91:1608-1615
30. Stanley JR: Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med 1995, 181:1-4
31. Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T: BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002, 30:224-232
32. Tsuji-Abe Y, Akiyama M, Yamanaka Y, Kikuchi T, Sato-Matsumura KC, Shimizu H: Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 2005, 37:145-149
33. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ: Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997, 109:573-579
34. Sitaru C, Schmidt E, Petermann S, Munteanu LS, Brocker EB, ZIllikens D: Autoantibodies to bullous pemphigoid antigen 180 induce dermalepidermal separation in cryosections of human skin. J Invest Dermatol 2002, 118:664-671